Enanta Pharmaceuticals Inc. (ENTA), a clinical-stage biotechnology company focusing on viral infections and immunological diseases, will be highlighting its investigational programs - Zelicapavir and EPS-3903 - at the American Thoracic Society (ATS) International Conference today.
Shares of Viemed Healthcare Inc. (VMD), a provider of home medical equipment and post-acute healthcare services in the United States, touched a new 52-week high of $10.10 during intraday trading yesterday. The company's sustained financial performance, combined with multiple growth engines, makes it a compelling long-term stock to watch.
Nektar Therapeutics (NKTR) entered a quiet period beginning this month as it awaits the trial results for its lead drug candidate, Rezpegaldesleukin, in alopecia areata. When we alerted readers to NKTR on June 11, 2025, it was trading at $11.25. The 52-week high of $78.81, recorded on April 1, 2026, reflects a gain of about 600% in ten months.
NRx Pharmaceuticals Inc. (NRXP), a clinical-stage biopharmaceutical company, is gearing up for key milestones this year as it advances its lead drug candidate NRX-100.
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.